October 2020

Department

Research in Review

10/21/2020

JCP Editors

Despite Utility, NGS Testing for Cancer Often Denied Insurance Coverage Expanded genomic panel testing was clinically impactful in nearly two-third of patients with high-risk cancer, yet payers reimbursed only...

...

10/21/2020

Journal of Clinical Pathways

Column

Editor's Page

Clinical Pathways Program Outcomes and User Experience

10/21/2020

Winston Wong, PharmD, Editor-in-Chief

The cancer care landscape continues to evolve. Not only do oncologists need to stay up to date on the latest treatment options for their patients, but also the age span of the general population is getting...

The...

10/21/2020

Journal of Clinical Pathways

Trending From ACCC

Innovators Share How To’s for Practice Transformation

10/21/2020

JCP Editors

In a recent “Ask the Board” column on how clinical pathways are growing, Journal of Clinical Pathways editorial advisory board member Ray Page, DO, PhD, FACOI, FASCO, shared his perspective: “As we continue to see...

In a...

10/21/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Making the Case for Genetic Testing in Clinical Pathways

10/21/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing literature...

...

10/21/2020

Journal of Clinical Pathways

Feature

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Lalan Wilfong, MD

Aimee Ginsburg, PharmD, BCPS

J Russell Hoverman, MD, PhD

John M Burke, MD

Leslie T Busby, MD

Angela Hsieh, PharmD, BCOP

Kartik Konduri, MD

Marcus A Neubauer, MD

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Perspectives

Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery

10/21/2020

Barbara McAneny, MD

Lee Schwartzberg, MD, FACP

Wui-Jin Koh, MD

Edward Arrowsmith, MD

Alison Fugaro, PA

Tyler Haydell

Paul J Hesketh, MD

Anita Pudusseri, DO

Sylvia Richey, MD

Corrine Zarwan, MD

Rebecca Stein

Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...

...

10/21/2020

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

October 2020

Department

Column

Feature

Current Issue

Special Reports

Subscribe

Volume 6

Specialties

Events

Year Round Education

HMP Global Products